Diabetes Care Volume 48, Supplement 1, January 2025 S337

Disclosures: Standards of Care in

Diabetes—2025
Diabetes Care 2025;48(Suppl. 1):S337–S343 | https://doi.org/10.2337/dc25-SDIS

Downloaded from http://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf by guest on 11 December 2024

Committee members disclosed the following financial or other dualities of interest covering the period 12 months before
December 2024
Other Speakers
research bureau and Ownership Consultant and
Member Employment Research grant support honoraria interest advisory board Other

American Diabetes Association Professional Practice Committee

DISCLOSURES
Nuha A. ElSayed American Diabetes None None None None None Endocrinologist, Joslin
(Co-Chair)§ Association, Harvard Diabetes Center;
Medical School Chair, Diabetes
Education for All

Rozalina G. University of Maryland University of Maryland None American Diabetes None None Editorial Board
McCoy School of Medicine, Baltimore,*# American Association Member, BMJ
(Co-Chair) University of Maryland Diabetes Association Medicine
Institute for Health
Computing

Grazia Aleppo Northwestern University Abbvie, Bayer, None None None Dexcom,* Insulet None
Feinberg School of Fractyl Health,#
Medicine Insulet,# MannKind,#
Tandem Diabetes,#
Welldoc*#

Raveendhara R. American Diabetes None None None None None None

Bannuru (Chief Association
Methodologist)§

Elizabeth A. Ohio University None None None None None Journal of

Beverly Heritage College of Osteopathic
Osteopathic Medicine, Medicine, Section
Ohio University Editor
Diabetes Institute

Kathaleen Briggs Pacific Northwest None None None None None Associate Editor, BMJ
Early University of Health Nutrition,
Sciences Prevention, &
Health

Dennis Bruemmer Cleveland Clinic Novartis*# None None None Esperion,* Bayer, None
Eli Lilly

Justin B. Echouffo- Johns Hopkins None None None None None Associate Editor,
Tcheugui University School Diabetes Care
of Medicine

Laya Ekhlaspour Division of Abbott,*# Beta Insulet,* Medtronic,* American Diabetes None Medtronic,* Diabetes Speaker at CME
Endocrinology, Bionics,*# Dexcom,*# Abbott,* Tandem Association Center Berne, Abbott,* educational
Department of MannKind,*# Diabetes Care* (honoraria), Insulet,* Tandem Diabetes program/grand
Pediatrics, University Medtronic,*# Tandem Medtronic,* Tandem Care,* Jaeb,* Sequel round sponsored
of California, Diabetes Care,*# Diabetes Care* by Sanofi
San Francisco Breakthrough T1D,*# (speakers bureau)
National Institutes of
Health*#

Continued on p. S338
S338 Disclosures Diabetes Care Volume 48, Supplement 1, January 2025

Other Speakers
research bureau and Ownership Consultant and
Member Employment Research grant support honoraria interest advisory board Other
Rajesh Garg David Geffen School of None None None None None Associate Editor, BMJ
Medicine at University Open Diabetes
of California, Los Research & Care
Angeles; Harbor-UCLA
Medical Center

Kamlesh Khunti University of Leicester AstraZeneca,*# None Amgen, None Amgen, AstraZeneca,* Diabetes Care
Boehringer AstraZeneca,* Bayer, Bayer, Berlin-Chemie editorial board
Ingelheim,*# Eli Lilly,*# Berlin-Chemie AG/ AG/Menarini Group, member
Merck Sharp & Menarini Group, Boehringer Ingelheim,*

Downloaded from http://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf by guest on 11 December 2024

Dohme,*# Novartis,*# Boehringer Daiichi-Sankyo, Eli Lilly,*
Novo Nordisk,*# Ingelheim,* Embecta, Merck Sharp
Sanofi*# Daiichi-Sankyo, & Dohme, Napp
Eli Lilly,* Merck Pharmaceuticals,
Sharp & Dohme, Novartis, Novo
Napp Nordisk,* Pfizer, Roche,
Pharmaceuticals, Sanofi, Servier,* Nestle
Novartis, Novo Health Science,
Nordisk,* Pfizer, Enbecta, Daiichi-Sankyo,
Roche, Sanofi, Pfizer
Servier,* Daiichi-
Sankyo, Pfizer

Rayhan Lal Stanford University Insulet, Medtronic, None None None Abbott Diabetes Care, None
Tandem Diabetes Care, Adaptyx Biosciences,
Sinocare Biolinq, Capillary
Biomedical, Deep Valley
Laboratories,
Eli Lilly, Gluroo,
PhysioLogic Devices,
Portal Insulin,
ProventionBio, Sanofi,
Tidepool

Ildiko Lingvay University of Texas Boehringer None None None AbbVie,* Altimmune, None
Southwestern Medical Ingelheim,*# Novo AstraZeneca,* Bayer,*
Center Nordisk,*# Sanofi*# Betagenon AB,* Bioio
Inc.,* Biomea,*
Boehringer-Ingelheim,*
Carmot,* Cytoki
Pharma,* Eli Lilly,*
Intercept,* Janssen/
Johnson & Johnson,*
Juvena,* Keros
Therapeutic, Inc.,*
Mediflix,* Merck,*
Metsera,* Novo
Nordisk,*#
Pharmaventures,*
Pfizer,* Regeneron,*
Sanofi,* Shionogi,*
Structure
Therapeutics,* Target
RWE,* Terns Pharma,*
The Comm Group,*
WebMD,* Zealand
Pharma*

Glenn Matfin National Health Service None None None None None None

Naushira Pandya Kiran C. Patel College of None None None None None Editorial Board,
Osteopathic Medicine, Journal of the
Nova Southeastern American Medical
University Directors
Association; Board

Continued on p. S339
diabetesjournals.org/care Disclosures S339

Other Speakers
research bureau and Ownership Consultant and
Member Employment Research grant support honoraria interest advisory board Other
Member, National
Association of
Geriatric
Education

Scott J. Pilla Johns Hopkins None None None None None None
University School of
Medicine

Sarit Polsky Barbara Davis Center Breakthrough T1D,# None Children’s Diabetes None Medtronic MiniMed, American College of
for Diabetes and The Leona H. and Foundation Inc. Diabetology

Downloaded from http://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf by guest on 11 December 2024

University of Colorado, Harry B. Helmsley (board member,
Anschutz Charitable Trust, conference
Medical Campus Dexcom# codirector)

Alissa R. Segal Massachusetts College None None MannKind None None Editorial Board
of Pharmacy & Health Member, Diabetes
Sciences, Brigham and Spectrum
Women’s Hospital

Jane Jeffrie Seley Weill Cornell Medicine None None None None None Associate Editor,
Diabetes Spectrum;
Section Co-Editor,
Current Diabetes
Reports; Editorial
Board Member,
Journal of Diabetes
Science &
Technology and
BMJ Open Diabetes
Research & Care

Robert C. Stanton Joslin Diabetes Center, None None None None None None
Beth Israel Deaconess
Medical Center, Harvard
Medical School

American Diabetes Association Scientific Team

Kirthikaa Balapattabi American Diabetes None None None None None None
Association

Elizabeth J. Pekas American Diabetes None None None None None None
Association

Designated Subject Matter Experts

Mandeep Bajaj Baylor College of American Diabetes None None None None Editor, BMJ Open
Medicine and Baylor St. Association-Diabetes Diabetes Research
Luke’s Medical Center Prevention Program and Care; ADA
grant*# Board of Directors

Brian C. Callaghan University of Michigan Lexicon*# None None None Dynamed, Vaccine Research contracts,
Injury Compensation American
Program Academy of
Neurology;
Associate Editor,
Neurology

Kenneth Cusi University of Florida Inventiva,# Boehringer Echosense, LabCorp, None None Arrowhead, Boehringer None
Ingelheim,# Perspectum Ingelheim, Eli Lilly,
MGGM Therapeutics,
Novo Nordisk,
ProSciento, Sagimet
Biosciences, Siemens
USA, Terns
Pharmaceuticals,
Zealand Pharma

Continued on p. S340
S340 Disclosures Diabetes Care Volume 48, Supplement 1, January 2025

Other Speakers
research bureau and Ownership Consultant and
Member Employment Research grant support honoraria interest advisory board Other
Sandeep R. Das University of Texas None None None None None None
Southwestern Medical
Center

Osagie Ebekozien T1D Exchange; Jannsen None Know Diabetes by None Sanofi, Medtronic None
University of Mississippi Pharmaceuticals, Heart, Vertex
School of Population Vertex Pharmaceuticals
Health Pharmaceuticals,
MannKind, Abbott, Eli
Lilly, Dexcom,

Downloaded from http://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf by guest on 11 December 2024

Breakthrough T1D,
Tandem Diabetes Care

Barbara Eichorst American Diabetes None None None None None None
Association

Talya K. Fleming Hackensack Meridian None None None None NeuroTechR3 None
JFK Johnson
Rehabilitation Institute,
Rutgers Robert Wood
Johnson Medical
School, Hackensack
Meridian School of
Medicine

Robert G. Frykberg Midwestern University None Biostem Arche Healthcare None Advanced Oxygen None
Therapy Inc., Biostem

Robert A. Gabbay† American Diabetes None None None None HealthReveal, Lark None
Association, Joslin Technologies, Onduo,*
Diabetes Center, StartUp Health,
Harvard Medical School Sweetech, Vida Health*

Jason L. Gaglia Joslin Diabetes Center, American Diabetes None None Vertex Avotres, Dyamyd, None
Harvard Medical School Association, Avotres,*# Pharmaceuticals*# Vertex
Diamyd Medical,*# Pharmaceuticals,*
Domp
e,*# Imcyse,*# Imcyse
Sanofi,*# Biomea*#

Rodolfo J. Galindo University of Miami Novo Nordisk,*# None American Diabetes None Abbott, AstraZeneca, UpToDate (authorship
Miller School of Boehringer Association, Bayer,* Boehringer royalties)
Medicine Ingelheim*# American Association Ingelheim, Dexcom, Eli
of Clinical Lilly,* HealthTrust GPO,
Endocrinology, The Novo Nordisk,
Endocrine Society, Medtronic, Monogram
Mayo Clinic, Emory Health
University, Florida
Endocrine
Association

Sunir J. Garg Wills Eye Hospital, American Academy of None None None American Academy of None
Thomas Jefferson Ophthalmology,# Ophthalmology, Apellis,
University Apellis,# Archimedic, Boehringer Ingelheim,
Bausch & Lomb,# Genentech, NGM Bio,
Boehringer Ingelheim,# Regeneron, Kodiak
Merck Manual,# Biosciences
Regeneron,# West
Pharmaceuticals,#
Zeiss#

Monica Girotra Memorial Sloan- None None None None None None
Kettering Cancer Center,
Weill Cornell Medical
College

Continued on p. S341
diabetesjournals.org/care Disclosures S341

Other Speakers
research bureau and Ownership Consultant and
Member Employment Research grant support honoraria interest advisory board Other
John M. Giurini Beth Israel Deaconess None None None None None None
Medical Center, Joslin
Diabetes Center

Mohamed Hassanein Dubai Health, None None Abbott, Eli Lilly, None Abbott, Eli Lilly, Novo None
Mohamed Bin Rashid Sanofi, Novo Nordisk, Sanofi
University Nordisk,
Servier

Mikhail N. Kosiborod Saint Luke’s Mid American College of Amgen,*# Amgen,*# Artera Health, 35Pharma,# Alnylam None
America Heart Institute, Cardiology AstraZeneca,*# AstraZeneca,*# Saghmos Pharmaceuticals,#

Downloaded from http://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf by guest on 11 December 2024

University of Missouri- Foundation,*# Bayer,*# Boehringer Bayer,*# Medcon Therapeutics Amgen,*# Applied
Kansas City School of AstraZeneca,*# Ingelheim,*# Medcon International, Novo Therapeutics,#
Medicine Boehringer International, Novo Nordisk,*# The AstraZeneca,*#
Ingelheim,*# CPC Nordisk,*# The Metabolic Institute Arrowhead
Clinical Research,*# Metabolic Institute of of America, Vifor Pharmaceuticals,#
Novo Nordisk,*# America, Vifor Pharma,*# Vox Bayer,*# Boehringer
University of Pharma*# Media Ingelheim,*# Corcept
Pittsburgh,*# Pfizer,*# Therapeutics,#
Vifor Pharma*# Cytokinetics,# Dexcom,#
Eli Lilly,# Esperion
Therapeutics,# Imbria
Pharmaceuticals,#Janssen
Pharmaceuticals,#
Lexicon
Pharmaceuticals,#
Medscape, Medcon
International,
Medtelligence, Merck,#
Novo Nordisk,*#
Pharmacosmos,#
Pfizer,*# Radcliffe
Cardiology, Regeneron,#
Roche,# Sanofi,#
scPharmaceuticals,#
Structure Therapeutics,#
The Metabolic Institute
of America, Translational
Medical Academy, Vifor
Pharma,*# Vox Media,
Youngene Therapeutics#

Robert F. Kushner Northwestern University None Novo Nordisk None None Altimmune, Boehringer Editor, Diabetes Care;
Feinberg School of Ingelheim, Eli Lilly, American Board of
Medicine Novo Nordisk, Weight Obesity Medicine,
Watchers, Structure, Board of Directors
Currax, Regeneron

Seymour R. Levin University of California, None None None None None None
Los Angeles

Roeland J.W. Joslin Diabetes Center, None None American Diabetes None None None
Middelbeek‡ Harvard Medical School Association

Lisa Murdock American Diabetes None None None None None None
Association

Nicola Napoli Fondazione Policlinico None None None Eli Lilly, Novo Eli Lilly, Novo Nordisk, None
Universitario Campus Nordisk Sanofi
Bio-Medico; Universita
Campus Bio-Medico di
Roma; School of
Medicine, Washington
University in St. Louis

Continued on p. S342
S342 Disclosures Diabetes Care Volume 48, Supplement 1, January 2025

Other Speakers
research bureau and Ownership Consultant and
Member Employment Research grant support honoraria interest advisory board Other
Joshua J. Neumiller College of Pharmacy None None None None Proteomics American Diabetes
and Pharmaceutical International Association Board
Sciences, Washington of Directors;
State University Editor, Diabetes
Spectrum;
National Kidney
Foundation,
scientific advisory
board member

Downloaded from http://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf by guest on 11 December 2024

Sharon J. Parish Weill Cornell Medical None None None None Catawba Acquisition None
College Newco LLC, Vella
Bioscience, Dare
Bioscience

Flavia Q. Pirih University of California None None None None None Associate Editor, Journal
School of Dentistry of Periodontology
and Clinical
Advances in
Periodontics;
Committee
Member, American
Academy of
Periodontology;
Committee
Member, Academy
for
Osteointegration;
California Society
for Periodontists,
Board Member

Elizabeth Selvin Welch Center for None American Diabetes American Diabetes None None Deputy Editor,
Prevention, Epidemiology Association Association* Diabetes Care*;
and Clinical Research; (honorarium) Editorial Board,
Johns Hopkins Bloomberg Diabetologia;
School of Public Health; Wolters Kluwer
Johns Hopkins School of (royalties);
Medicine UpToDate
(royalties)

Shylaja Srinivasan University of Abbott*# None None None None None

California, San Francisco

Molly L. Tanenbaum Stanford University None None None None None None
School of Medicine

Patti Urbanski Aspirus St. Luke’s None None American Association None Embecta Diabetes CDCES Review Guide
of Diabetes author; Core
Educators, American Concepts course
Diabetes Association faculty, American
(honorarium) Association of
Diabetes
Educators;
American Diabetes
Association Board
of Directors

Monica Verduzco- University of Texas Ipsen Pharma *# Ipsen Pharma,* Merz Ipsen Pharma,* None Ipsen Pharma,* None
Gutierrez Health Science Center Pharmaceuticals* AbbVie, Merz AbbVie, Merz
at San Antonio Pharmaceuticals* Pharmaceuticals*

Crystal C. Woodward American Diabetes None None None None None None
Association

Continued on p. S343
diabetesjournals.org/care Disclosures S343

Other Speakers
research bureau and Ownership Consultant and
Member Employment Research grant support honoraria interest advisory board Other
Zobair M. Younossi The Global NASH Madrigal None None None Abbott, Boehringer None
Council; Beatty Liver Pharmaceuticals,*# Ingelheim, Cymabay,
and Obesity Research Novo Nordisk,*# Ipsen, Novo Nordisk,
Program, Inova Health Siemens*# Madrigal
System Pharmaceuticals*

*$$10,000 per year from company to individual. #Grant or contract is to university or other employer. §Nuha A. ElSayed and Raveendhara R. Bannuru are also part of the Ameri-
can Diabetes Association Scientific Team. †Robert A. Gabbay is former American Diabetes Association staff. ‡Roeland J.W. Middelbeek is now employed by Novo Nordisk, and all of
his work on the guidelines was completed prior to his position start date.

Downloaded from http://diabetesjournals.org/care/article-pdf/48/Supplement_1/S337/791487/dc25sdis.pdf by guest on 11 December 2024